Picture of BioLife Solutions logo

BLFS BioLife Solutions Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for BioLife Solutions, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
C2020
December 31st
C2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-1.661.98-8.91-140-66.4
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items7.093.9913.813540.2
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-4.47-1.1-2.26-14.91.47
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities1.216.64-4.59-8.49-12.5
Capital Expenditures-2.33-7.81-14.8-13.9-11.2
Purchase of Fixed Assets
Other Investing Cash Flow Items-24.7-16.91.56-44.229.1
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities-27-24.7-13.2-58.117.8
Financing Cash Flow Items0.415-0.499-1.3-1.840.338
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities1.6102-2.7816.310.6
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-24.284-20.6-50.416